Literature DB >> 21244169

Effects of diurnal variation and caffeine consumption on Test of Variables of Attention (TOVA) performance in healthy young adults.

Melissa G Hunt1, Ani J Momjian1, Keri K Wong1.   

Abstract

The Test of Variables of Attention (TOVA) is a continuous performance test (CPT) that assesses attention, impulsivity, and processing speed. CPTs are used in the assessment of attention-deficit/hyperactivity disorder (ADHD) in children, but more young adults are being assessed for ADHD as well. The TOVA norms are based on a standardization sample that was tested early in the day, and any TOVA administered after 1:00 p.m. will be flagged as potentially invalid. Whereas the testing time recommendations make sense for pediatric samples, it is unclear whether they are appropriate for young adults in college, who typically show significant phase delay in their diurnal rhythms. In addition, many college students consume large amounts of caffeine, and it is unclear how caffeine consumption affects TOVA performance. The current study examined the impact of time of day, self-reported diurnal preference, and caffeine consumption on TOVA performance in a double-blind, placebo-controlled experiment with healthy college students. There was evidence of diurnal variation on average response time and impulsivity but not on overall ADHD score, with participants tested in the afternoon responding faster but making more commission errors than did participants tested in the morning. Caffeine consumption led to significantly faster response times, but only for participants who typically consumed relatively little caffeine. We conclude that the TOVA can be administered to young adults outside the recommended time constraints without compromising the validity of test score interpretation but that the caffeine consumption of participants should be closely monitored.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21244169     DOI: 10.1037/a0021401

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  7 in total

1.  Caffeine intake and cognitive functions in children.

Authors:  Han Zhang; Zu Xuan Lee; Anqi Qiu
Journal:  Psychopharmacology (Berl)       Date:  2020-06-29       Impact factor: 4.530

2.  Missed targets, reaction times, and arousal are related to trait anxiety and attention to pain during an experimental vigilance task with a painful target.

Authors:  Nichole M Emerson; Timothy J Meeker; Joel D Greenspan; Mark I Saffer; Claudia M Campbell; Anna Korzeniewska; Fred A Lenz
Journal:  J Neurophysiol       Date:  2019-10-09       Impact factor: 2.714

Review 3.  Caffeine as an attention enhancer: reviewing existing assumptions.

Authors:  Suzanne J L Einöther; Timo Giesbrecht
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

4.  Physiological parameters of mental health predict the emergence of post-traumatic stress symptoms in physicians treating COVID-19 patients.

Authors:  T Dolev; S Zubedat; Z Brand; B Bloch; E Mader; O Blondheim; A Avital
Journal:  Transl Psychiatry       Date:  2021-03-15       Impact factor: 6.222

Review 5.  Behavioral, Physiological and EEG Activities Associated with Conditioned Fear as Sensors for Fear and Anxiety.

Authors:  Jui-Hong Chien; Luana Colloca; Anna Korzeniewska; Timothy J Meeker; O Joe Bienvenu; Mark I Saffer; Fred A Lenz
Journal:  Sensors (Basel)       Date:  2020-11-26       Impact factor: 3.576

6.  Effects of schooling on aspects of attention in rural Burkina Faso, West Africa.

Authors:  Anselme Simeon Sanou; Abdoulaye Hama Diallo; Penny Holding; Victoria Nankabirwa; Ingunn Marie S Engebretsen; Grace Ndeezi; James K Tumwine; Nicolas Meda; Thorkild Tylleskar; Esperance Kashala-Abotnes
Journal:  PLoS One       Date:  2018-09-05       Impact factor: 3.240

7.  Validation of Psychophysiological Measures for Caffeine Oral Films Characterization by Machine Learning Approaches.

Authors:  Patrícia Batista; Pedro Miguel Rodrigues; Miguel Ferreira; Ana Moreno; Gabriel Silva; Marco Alves; Manuela Pintado; Patrícia Oliveira-Silva
Journal:  Bioengineering (Basel)       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.